These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 36537528)

  • 21. Recent Updates to Clinical Practice Guidelines for Diabetes Mellitus.
    Yu J; Lee SH; Kim MK
    Endocrinol Metab (Seoul); 2022 Feb; 37(1):26-37. PubMed ID: 35255599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How use of continuous glucose monitoring can address therapeutic inertia in primary care.
    Martens TW; Parkin CG
    Postgrad Med; 2022 Aug; 134(6):576-588. PubMed ID: 35584802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ISPAD Clinical Practice Consensus Guidelines 2018: Glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes.
    DiMeglio LA; Acerini CL; Codner E; Craig ME; Hofer SE; Pillay K; Maahs DM
    Pediatr Diabetes; 2018 Oct; 19 Suppl 27():105-114. PubMed ID: 30058221
    [No Abstract]   [Full Text] [Related]  

  • 24. Efficacy and safety comparison of continuous glucose monitoring and self-monitoring of blood glucose in type 1 diabetes: systematic review and meta-analysis.
    Wojciechowski P; Ryś P; Lipowska A; Gawęska M; Małecki MT
    Pol Arch Med Wewn; 2011 Oct; 121(10):333-43. PubMed ID: 22045094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of divergent continuous glucose monitoring technologies on glycaemic control in type 1 diabetes mellitus: A systematic review and meta-analysis of randomised controlled trials.
    Elbalshy M; Haszard J; Smith H; Kuroko S; Galland B; Oliver N; Shah V; de Bock MI; Wheeler BJ
    Diabet Med; 2022 Aug; 39(8):e14854. PubMed ID: 35441743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) endorsed by JDRF and supported by the American Diabetes Association (ADA).
    Moser O; Riddell MC; Eckstein ML; Adolfsson P; Rabasa-Lhoret R; van den Boom L; Gillard P; Nørgaard K; Oliver NS; Zaharieva DP; Battelino T; de Beaufort C; Bergenstal RM; Buckingham B; Cengiz E; Deeb A; Heise T; Heller S; Kowalski AJ; Leelarathna L; Mathieu C; Stettler C; Tauschmann M; Thabit H; Wilmot EG; Sourij H; Smart CE; Jacobs PG; Bracken RM; Mader JK
    Diabetologia; 2020 Dec; 63(12):2501-2520. PubMed ID: 33047169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Population-Level Impact and Cost-effectiveness of Continuous Glucose Monitoring and Intermittently Scanned Continuous Glucose Monitoring Technologies for Adults With Type 1 Diabetes in Canada: A Modeling Study.
    Rotondi MA; Wong O; Riddell M; Perkins B
    Diabetes Care; 2022 Sep; 45(9):2012-2019. PubMed ID: 35834175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Consensus guidelines for glycemic monitoring in type 1/type 2 & GDM.
    Kesavadev J; Sadikot S; Wangnoo S; Kannampilly J; Saboo B; Aravind SR; Kalra S; Makkar BM; Maji D; Saikia M; Anjana RM; Rajput R; Singh SK; Shah S; Dhruv U; Vishwanathan V
    Diabetes Metab Syndr; 2014; 8(3):187-95. PubMed ID: 25200925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High Glycemic Variability Is Associated with Worse Continuous Glucose Monitoring Metrics in Children and Adolescents with Type 1 Diabetes.
    Piona C; Marigliano M; Mozzillo E; Di Candia F; Zanfardino A; Iafusco D; Maltoni G; Zucchini S; Delvecchio M; Maffeis C
    Horm Res Paediatr; 2021; 94(9-10):369-373. PubMed ID: 34915493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of Technology in Older Adults with Type 1 Diabetes: Clinical Characteristics and Glycemic Metrics.
    Munshi M; Slyne C; Davis D; Michals A; Sifre K; Dewar R; Atakov-Castillo A; Toschi E
    Diabetes Technol Ther; 2022 Jan; 24(1):1-9. PubMed ID: 34524033
    [No Abstract]   [Full Text] [Related]  

  • 31. CGM Benefits and Burdens: Two Brief Measures of Continuous Glucose Monitoring.
    Messer LH; Cook PF; Tanenbaum ML; Hanes S; Driscoll KA; Hood KK
    J Diabetes Sci Technol; 2019 Nov; 13(6):1135-1141. PubMed ID: 30854886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuous blood glucose monitoring in diabetes treatment.
    Vazeou A
    Diabetes Res Clin Pract; 2011 Aug; 93 Suppl 1():S125-30. PubMed ID: 21864744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
    Riemsma R; Corro Ramos I; Birnie R; Büyükkaramikli N; Armstrong N; Ryder S; Duffy S; Worthy G; Al M; Severens J; Kleijnen J
    Health Technol Assess; 2016 Feb; 20(17):v-xxxi, 1-251. PubMed ID: 26933827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The efficacy of outpatient monitoring of children and adolescents with type 1 diabetes with regular use of professional continuous glucose monitoring].
    Peterkova VA; Emelyanov AO; Laptev DN; Samoylova YG; Khramova EB; Petriaikina EE; Rybkina IG; Filimonova AY
    Probl Endokrinol (Mosk); 2020 Aug; 66(1):14-22. PubMed ID: 33351309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beyond HbA1c.
    Bloomgarden Z
    J Diabetes; 2017 Dec; 9(12):1052-1053. PubMed ID: 28792665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of flash glucose monitoring with real time continuous glucose monitoring in children and adolescents with type 1 diabetes treated with continuous subcutaneous insulin infusion.
    Massa GG; Gys I; Bevilacqua E; Wijnands A; Zeevaert R
    Diabetes Res Clin Pract; 2019 Jun; 152():111-118. PubMed ID: 31121275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utility of Continuous Glucose Monitoring in Type 1 and Type 2 Diabetes.
    Toschi E; Wolpert H
    Endocrinol Metab Clin North Am; 2016 Dec; 45(4):895-904. PubMed ID: 27823610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of real time continuous glucose monitoring or flash glucose monitoring in the management of diabetes: A consensus view of Italian diabetes experts using the Delphi method.
    Bruttomesso D; Laviola L; Avogaro A; Bonora E; Del Prato S; Frontoni S; Orsi E; Rabbone I; Sesti G; Purrello F;
    Nutr Metab Cardiovasc Dis; 2019 May; 29(5):421-431. PubMed ID: 30952574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Real-World Studies Support Use of Continuous Glucose Monitoring in Type 1 and Type 2 Diabetes Independently of Treatment Regimen.
    Gavin JR; Bailey CJ
    Diabetes Technol Ther; 2021 Sep; 23(S3):S19-S27. PubMed ID: 34165343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Continuous Glucose Monitoring Within Hospital: A Scoping Review and Summary of Guidelines From the Joint British Diabetes Societies for Inpatient Care.
    Avari P; Lumb A; Flanagan D; Rayman G; Misra S; Dhatariya K; Choudhary P
    J Diabetes Sci Technol; 2023 May; 17(3):611-624. PubMed ID: 36444418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.